Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:18   Issue: 8
Pp: 719-719
M. Haber
DOI: 10.2174/156800961808180829102109



The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies

Volume:18   Issue: 8
Pp: 720-736
Avineesh Singh, Preeti Patel, Jageshwar, Vijay Kumar Patel, Deepak Kumar Jain, M. Kamal and Harish Rajak*
DOI: 10.2174/1568009617666170630124643




Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents

Volume:18   Issue: 8
Pp: 737-748
Leila Farahmand, Parnaz Merikhian, Neda Jalili, Behrad Darvishi and Keivan Majidzadeh-A*
DOI: 10.2174/1568009617666170623113520




p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

Volume:18   Issue: 8
Pp: 749-772
Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra
DOI: 10.2174/1568009617666170623111953




Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer

Volume:18   Issue: 8
Pp: 773-791
Dhaval Sanchala, Lokesh K. Bhatt* and Kedar S. Prabhavalkar
DOI: 10.2174/1568009617666170623123848




Development of Drug Targeting and Delivery in Cervical Cancer

Volume:18   Issue: 8
Pp: 792-806
Urvashi Aggarwal, Amit Kumar Goyal and Goutam Rath*
DOI: 10.2174/1568009617666171009165105




A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent

Volume:18   Issue: 8
Pp: 807-815
Rand R. Hafidh*, Saba Z. Hussein, Mohammed Q. MalAllah, Ahmed S. Abdulamir and Fatimah Abu Bakar
DOI: 10.2174/1568009617666171114144236




JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells

Volume:18   Issue: 8
Pp: 816-828
Ilaria Zanellato*, Donato Colangelo and Domenico Osella
DOI: 10.2174/1568009617666170623101722